https://www.selleckchem.com/pr....oducts/CP-690550.htm
Here we sought to clarify the prognostic impact of sarcopenia-related markers (grip strength (GS), muscle mass using bioimpedance analysis and patient quality of life as assessed by the 36-Item Short-Form Health Survey (SF36)) in patients with chronic liver diseases (CLDs, n = 411; 160 liver cirrhosis patients; median age, 64 years) on the incidence of composite hepatic events (CHEs). A GS decrease was defined as less then 26 kg in men and less then 18 kg in women, while a skeletal muscle mass index (SMI) decrease was defined as less
Like
Comment
Share
